|Articles|April 20, 2016

Bracket Announces Platform Updates

Bracket announced platform updates to their eCOA and RTSM products to include support for text messaging with patients and other stakeholders in clinical research programs.

Read the full release here

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership

Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies

Breaking the Efficacy Ceiling in IBD and Beyond

The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research

ACT Brief: Substance Versus Branding in Biotech Support, Site-Level Execution Gaps and Point-of-Care Data, and KCNT1-Targeted Pediatric Epilepsy Program

Bracket Announces Platform Updates

Related Content

The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research

Breaking the Efficacy Ceiling in IBD and Beyond

ACT Brief: Substance Versus Branding in Biotech Support, Site-Level Execution Gaps and Point-of-Care Data, and KCNT1-Targeted Pediatric Epilepsy Program

Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies

How to Tell Substance from Branding in Biotech's Support Ecosystem

Trending on Applied Clinical Trials Online

FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership

Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies

Breaking the Efficacy Ceiling in IBD and Beyond

The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research

ACT Brief: Substance Versus Branding in Biotech Support, Site-Level Execution Gaps and Point-of-Care Data, and KCNT1-Targeted Pediatric Epilepsy Program